Late decelerations vs variable decelerations: nursing action steps

LS
By Lindsay Smith, AGPCNP
Updated October 5, 2026

Reviewed for clinical accuracy · Methodology: NIH, NCBI, AANP guidelines

Electronic fetal monitoring (EFM) is the most widely used tool for assessing fetal well-being during labor: ACOG’s 2025 guideline notes that nearly 90% of pregnant patients in the United States are monitored with it. Its evidence base is mixed. In the Cochrane review of randomized trials, continuous EFM halved neonatal seizures compared with intermittent auscultation but did not reduce perinatal death or cerebral palsy, and it raised the cesarean rate (RR 1.63). Understanding what you see on a fetal monitor strip – and what it requires you to do – is one of the most heavily tested clinical competencies in nursing licensure exams and a skill you will use on every labor and delivery shift. This reference covers the full NICHD classification framework, every deceleration type, intrauterine resuscitation, and the documentation requirements your board exam and clinical practice both expect.

What electronic fetal monitoring measures

EFM tracks two parameters simultaneously:

  • Fetal heart rate (FHR): recorded in beats per minute (bpm) on the upper channel of the strip
  • Uterine activity (UA): contractions recorded in millimeters of mercury (mmHg) on the lower channel

The relationship between these two channels is the foundation of strip interpretation. Read the FHR against the contraction pattern beneath it: what matters is how the fetal heart responds to each contraction.

External vs internal monitoring methods

External vs internal fetal monitoring methods
Method Device What it measures Requirements / limitations
External monitoring Doppler ultrasound transducer (FHR) plus a tocotransducer (toco) for contractions, both belted to the abdomen FHR via Doppler; contraction frequency and duration via pressure sensor No ROM or cervical dilation required; cannot measure contraction intensity or resting tone; signal loss is common with class III obesity, fetal movement, and late second stage, and the maternal heart rate can be recorded in error
Fetal scalp electrode (FSE) Spiral electrode attached directly to fetal presenting part Direct fetal ECG → more precise FHR tracing Requires ruptured membranes, enough cervical dilation to reach the presenting part, and a known vertex presentation. Absolute contraindications (ACOG CPG No. 10): malpresentation or unknown presenting part, HIV with viral load >1,000 copies/mL, active genital HSV lesions, placenta or vasa previa, suspected fetal bleeding disorder. Maternal hepatitis B or C is a relative contraindication. Avoid routine use: scalp injury and cephalohematoma risk is low but real
Intrauterine pressure catheter (IUPC) Fluid-filled or solid-state catheter placed inside uterus True intrauterine pressure in mmHg; allows Montevideo unit calculation Requires ruptured membranes; used when contraction adequacy is in question or oxytocin titration requires precision

Baseline fetal heart rate

Normal baseline FHR is 110–160 bpm: the mean FHR, rounded to increments of 5 bpm, over a 10-minute window excluding accelerations, decelerations, periods of marked variability, and segments that differ by more than 25 bpm. At least 2 minutes of identifiable baseline are needed in that window; otherwise the baseline is indeterminate and you refer to the prior 10-minute segment. The baseline represents the resting FHR when the fetus is not responding to a contraction or other stimulus.

  • Tachycardia: baseline >160 bpm for ≥10 minutes. Causes include maternal fever, chorioamnionitis, fetal infection, prematurity, hyperthyroidism, and certain medications (terbutaline, atropine).
  • Bradycardia: baseline <110 bpm for ≥10 minutes. Causes include prolonged cord compression, maternal hypothermia, fetal heart block, and post-epidural hypotension.

Tachycardia or bradycardia alone does not define Category III – the presence or absence of variability and the overall clinical picture determine category assignment.

Baseline variability

Variability describes the irregular fluctuations in the FHR baseline, measured peak to trough. It reflects the interaction between the fetal sympathetic and parasympathetic nervous systems. Moderate variability and accelerations are the two features that most reliably predict the absence of fetal acidemia at the time of observation.

Variability typeAmplitude rangeClinical meaning
AbsentUndetectableHighest concern; associated with hypoxia/acidosis or CNS depression
MinimalDetectable but ≤5 bpmMay indicate fetal sleep cycle (commonly 20–40 min), sedating medications, or developing compromise
Moderate6–25 bpmNormal; reassuring of intact CNS function
Marked>25 bpmCategory II finding; its meaning is less well defined than the other bands, so evaluate it in the clinical context

Moderate variability is the most reassuring finding on any strip. Category III requires absent variability (or a sinusoidal pattern), so a tracing with moderate variability cannot be Category III by definition.

Accelerations

An acceleration is a visually apparent abrupt increase in FHR above the baseline (onset to peak in less than 30 seconds):

  • ≥32 weeks gestation: peak ≥15 bpm above baseline, lasting ≥15 seconds but <2 minutes
  • <32 weeks gestation: peak ≥10 bpm above baseline, lasting ≥10 seconds but <2 minutes
  • Prolonged acceleration: 2 minutes or more but less than 10 minutes; 10 minutes or longer is a baseline change

True fetal accelerations are reassuring. They indicate an intact and responsive fetal autonomic nervous system. One caution: an “acceleration” that rises with every push in the second stage is a classic sign that the external monitor is recording the maternal heart rate. Confirm with a maternal pulse oximeter, and consider a fetal scalp electrode if the two cannot be separated. Two or more accelerations in 20 minutes constitute a reactive non-stress test (NST). Absence of accelerations alone is not diagnostic of compromise, but it moves interpretation toward Category II.

NICHD three-tier classification system

The National Institute of Child Health and Human Development (NICHD), ACOG, and SMFM established the three-tier classification system in 2008 to standardize strip interpretation, and ACOG’s Clinical Practice Guideline No. 10 (2025) carries it forward. Whatever system a unit uses, nurses and clinicians on that unit must use the same one. AWHONN treats documenting the category as optional; follow your institution’s policy.

NICHD FHR category classification
Category Criteria Interpretation Nursing response
Category I – Normal Baseline 110–160 bpm
Moderate variability
Late/variable decelerations: absent
Early decelerations: present or absent
Accelerations: present or absent 		Normal fetal acid-base status at time of observation. Predictive of normal fetal neurological status. Routine intrapartum care. Reassess per unit protocol (AWHONN: every 30 min in the active phase and every 15 min during active pushing; every 15 and every 5 min with oxytocin or risk factors).
Category II – Indeterminate Any FHR tracing not categorized as I or III. Examples: minimal variability; absent variability without recurrent decelerations; marked variability; tachycardia; bradycardia without absent variability; recurrent variable or recurrent late decelerations with minimal or moderate variability; prolonged deceleration 2–10 min; variable decelerations with slow return, overshoots, or "shoulders"; no acceleration after fetal stimulation Indeterminate. Does not predict abnormal fetal acid-base status, but insufficient evidence to classify as normal. Requires evaluation and surveillance. Higher-risk features: absent variability, prolonged unexplained minimal variability, unexplained new tachycardia, recurrent late or variable decelerations, or more than one prolonged deceleration. Initiate intrauterine resuscitation measures. Notify provider. Increase monitoring frequency. Identify and correct reversible causes. Reassess continuously for progression toward Category I or III.
Category III – Abnormal Sinusoidal pattern, OR
Absent variability WITH any of: recurrent late decelerations, recurrent variable decelerations, or bradycardia 		Abnormal fetal acid-base status. Associated with increased risk of fetal hypoxic injury. Immediate provider notification. Initiate all intrauterine resuscitation steps simultaneously. Prepare for expedited delivery (operative vaginal or cesarean) if the tracing does not resolve. Do not delay in hope of spontaneous improvement.

Most of labor is spent in Category I. In a 10-hospital study of 48,444 term labors, Category I was present 77.9% of the time and Category II 22.1%, with Category II rising to 39.1% in the last 2 hours before birth. Category III is rare (under 1% of tracings per ACOG). The category is not a permanent label – strips can shift between categories as labor progresses, resuscitation measures are applied, or clinical conditions change.

Deceleration types

Decelerations are temporary drops in FHR below the baseline. The four types are distinguished by their timing relative to contractions, their shape, and their underlying mechanism. For a quick mnemonic summary of cause-to-deceleration mapping, see the VEAL CHOP mnemonic page.

Deceleration types: mechanism, appearance, significance, and nursing action
Type Mechanism Strip appearance Clinical significance Nursing action
Early deceleration Fetal head compression during contraction → vagal stimulation → FHR slows Gradual onset (30 seconds or more from onset to nadir) and return; mirrors the contraction in shape and timing; nadir occurs at peak of contraction; uniform appearance Benign and reassuring. Common in active labor with engagement. No indication of fetal compromise. Continue monitoring. No intervention required. Document.
Late deceleration Uteroplacental insufficiency → transient fetal hypoxia → myocardial depression and chemoreceptor response Gradual onset (30 seconds or more from onset to nadir) and return; delayed relative to the contraction, so in most cases onset, nadir, and recovery each occur after the beginning, peak, and end of the contraction; uniform shape Concerning. Recurrent late decelerations indicate inadequate uteroplacental oxygen transfer. With minimal or moderate variability they are Category II (a higher-risk feature); with absent variability → Category III. Position change. IV fluid bolus. Reduce or stop oxytocin. Look for and treat maternal hypotension. Notify provider. Prepare for possible delivery if no improvement.
Variable deceleration Umbilical cord compression → abrupt FHR drop Abrupt onset (less than 30 seconds from onset to nadir); drop of 15 bpm or more lasting 15 seconds to less than 2 minutes; V-, U-, or W-shaped; onset, depth, and duration vary from contraction to contraction Isolated variable decelerations with moderate variability are often benign. Become concerning when they recur with most contractions, deepen or lengthen, return slowly to baseline, show overshoots or "shoulders" (NICHD lists these as Category II features), or come with falling variability. Larger deceleration area (depth × duration) predicts fetal acidemia. Reposition (lateral or knee-chest). Amnioinfusion if ordered. Assess for cord prolapse. Notify provider if prolonged or severe. See cord prolapse nursing for emergency cord compression management.
Prolonged deceleration Multiple potential causes: cord prolapse, uterine hyperstimulation, maternal hypotension, epidural placement, vagal response to vaginal exam FHR drop ≥15 bpm below baseline lasting ≥2 minutes but <10 minutes. If ≥10 minutes → reclassify as baseline change. Serious. Requires immediate assessment and correction of cause. A single prolonged deceleration may precede rapid deterioration. Initiate full intrauterine resuscitation protocol. Call provider immediately. Identify cause. Prepare for possible emergency delivery.

Sinusoidal pattern

A sinusoidal pattern is a visually apparent, smooth, sine wave–like undulating FHR baseline with a cycle frequency of 3–5 per minute that persists for 20 minutes or more. There is no normal variability within the oscillation and accelerations are absent.

The sinusoidal pattern is a Category III finding and always requires immediate provider notification. It signals fetal anemia, for example from:

  • Red-cell alloimmunization (such as anti-D) or fetomaternal hemorrhage
  • Ruptured vasa previa, where the bleeding is fetal blood
  • Severe anemia advanced enough to cause hydrops fetalis

ACOG notes that no intrauterine resuscitation measure helps a sinusoidal pattern lasting more than 30 minutes, so the plan is expeditious delivery. A short-lived sinusoidal-looking pattern can follow maternal opioid administration and resolves as the drug wears off. Differentiating the two requires clinical correlation; when in doubt, treat it as sinusoidal until ruled out.

Intrauterine resuscitation

Intrauterine resuscitation (IUR) is a set of interventions designed to optimize uteroplacental blood flow and fetal oxygenation when a non-reassuring FHR pattern develops. Steps are initiated simultaneously, not sequentially.

Intrauterine resuscitation steps: action and rationale
Action Rationale Priority
Position patient in left lateral (or right lateral if no improvement) Relieves aortocaval compression from the gravid uterus; increases uterine perfusion and venous return First-line; do immediately
IV fluid bolus (commonly 500–1,000 mL isotonic crystalloid per order) Treats maternal hypotension (common after epidural) and increases circulating volume to improve uteroplacental perfusion. Use caution with preeclampsia or other fluid-overload risk First-line; do immediately
Treat maternal hypotension: IV vasopressor as ordered; ask anesthesia about reducing the epidural infusion if hypotension recurs Restores placental perfusion when FHR changes follow a drop in maternal blood pressure When hypotension is present
Amnioinfusion (provider order; requires ruptured membranes and an IUPC) Recommended by ACOG for recurrent variable decelerations from cord compression For recurrent variables not resolved by position change
Discontinue oxytocin (or misoprostol/dinoprostone if applicable) Removes exogenous cause of uterine hyperstimulation; reduces contraction frequency and duration to restore inter-contraction recovery time for the fetus First-line if oxytocin is infusing
Oxygen supplementation (10 L/min via non-rebreather mask) if maternal oxygen saturation is low Corrects maternal hypoxemia when present. ACOG Clinical Practice Guideline No. 10 (October 2025) recommends against routine maternal oxygen for Category II or Category III tracings in the absence of maternal hypoxia (strong recommendation, high-quality evidence): a 2021 meta-analysis of 16 randomized trials found no improvement in umbilical artery pH. AWHONN's 2022 response is narrower: oxygen should not be first-line, but a 15–30 minute trial may be reasonable in selected cases (minimal or absent variability with recurrent late, variable, or prolonged decelerations) after other measures have failed. Follow your unit's protocol. Indicated for maternal hypoxia; not routine for Category II or III
Notify provider Provider must be aware of pattern, category, and response to resuscitation to determine escalation plan Concurrent with resuscitation; do not wait
Assess and treat underlying cause Hypotension, cord compression, uterine tachysystole, maternal fever each require specific interventions beyond IUR basics Concurrent; guided by clinical assessment
Prepare for operative delivery if no response ACOG recommends expedited delivery for a Category III tracing that does not respond to initial resuscitation. CPG No. 10 sets no fixed waiting time; urgency depends on the cause (suspected uterine rupture with bradycardia needs delivery as fast as is safely possible). Category III is not a waiting diagnosis. Escalation; triggered by non-response

For tachysystole specifically (>5 contractions in 10 minutes averaged over 30 minutes), stopping or reducing oxytocin is the primary intervention. If tachysystole persists despite pausing oxytocin and the tracing is Category III or Category II with high-risk features, ACOG suggests a rapid-acting uterine relaxant such as terbutaline (commonly 0.25 mg subcutaneous, per order).

Nursing documentation requirements

ACOG’s 2025 guideline leaves assessment and documentation frequency to hospital protocol. Most protocols build on AWHONN’s position statement:

  • Strip assessment frequency (continuous EFM): low-risk without oxytocin, every 30 minutes in the active phase and during passive fetal descent, every 15 minutes during active pushing. With oxytocin or risk factors (e.g., preeclampsia, prior uterine surgery), every 15 minutes in the active phase and passive descent, every 5 minutes during active pushing. Assess before and after every oxytocin dose change.
  • Assessment vs charting: with continuous EFM the tracing itself records the data, so AWHONN accepts summary documentation at intervals set by facility policy, provided the record shows how often you assessed and what you concluded.
  • Elements to document: FHR baseline, baseline variability, presence/absence of accelerations, deceleration type(s) if present, uterine activity (frequency, duration, intensity, resting tone), and nursing interventions if any. NICHD category is optional in AWHONN’s statement but required by many hospitals.
  • Interventions and responses: document every intervention and the FHR response to each, including time of provider notification and provider’s response.
  • Significant events: document strip category at time of any significant event (rupture of membranes, epidural placement, delivery of infant, administration of medications affecting FHR).

Document using standardized NICHD terminology – not lay terms. Write “late deceleration with moderate variability, Category II” rather than “FHR dipped after contraction, looks okay.”

Conditions affecting EFM interpretation

Several clinical contexts alter baseline FHR or variability and must be factored into interpretation:

  • Preterm fetus (<32 weeks): lower baseline variability and smaller acceleration amplitude are normal due to CNS immaturity
  • Medications: opioids and benzodiazepines decrease variability; betamethasone can transiently reduce variability, most noticeably on day 2 after dosing, with values back to pretreatment levels by about day 3; magnesium sulfate (used in preterm labor and preeclampsia) reduces variability; see preterm labor nursing for magnesium monitoring details
  • Fetal sleep cycle: minimal variability during a sleep cycle (commonly 20–40 minutes) is normal; vibroacoustic or scalp stimulation that produces an acceleration is reassuring, but a 2023 Cochrane review found no clear evidence that scalp stimulation is a reliable test of fetal well-being, so the absence of a response is not diagnostic
  • Epidural analgesia: may cause maternal hypotension after placement or a bolus, producing a prolonged deceleration or late decelerations; IV bolus, position change, and vasopressors as ordered are first-line

For high-acuity OB scenarios including placenta previa, abruption, and severe preeclampsia, continuous EFM is standard. See placenta previa and abruption nursing and preeclampsia nursing for those management pathways. In the event of a deteriorating FHR pattern alongside a shoulder dystocia, review the shoulder dystocia nursing protocol. For postpartum deterioration following delivery, postpartum hemorrhage nursing covers the immediate assessment sequence.

The obstetric nursing reference provides a broader overview of labor stages, analgesia, and maternal assessment alongside fetal monitoring concepts.

NCLEX tips: high-yield exam distinctions

1. Early decelerations never require intervention. Early decelerations mirror contractions (onset with contraction, nadir at peak, recovery with end of contraction). They reflect head compression – benign vagal stimulation. The correct NCLEX action is to continue monitoring and document.

2. Late decelerations require immediate action – starting with position change and stopping oxytocin. On NCLEX, when a patient is receiving oxytocin and develops late decelerations, the priority sequence is: (1) reposition to left lateral, (2) stop the oxytocin infusion, (3) increase IV fluid rate, (4) notify provider. Do not increase the oxytocin. Do not simply “document and continue monitoring.”

3. Variable decelerations need escalation when they are deep, long, recurrent, or slow to recover. Isolated brief variable decelerations with moderate variability are common and usually benign, especially with maternal position change. Older teaching used a “rule of 60s” (deeper than 60 bpm or longer than 60 seconds) to flag severe variables. NICHD 2008 dropped depth grading, but the idea holds: in a prospective cohort, a larger total deceleration area (depth × duration) was the most predictive of the patterns studied for fetal acidemia (AUC 0.76). Red flags that call for provider notification are recurrence with most contractions, increasing depth or duration, slow return to baseline, overshoots or “shoulders,” and loss of variability.

4. Sinusoidal pattern = Category III until proven otherwise. On NCLEX, a sinusoidal pattern is always treated as an emergency. It indicates fetal anemia (think red-cell alloimmunization, fetomaternal hemorrhage, ruptured vasa previa). The correct action is immediate provider notification and preparation for delivery, not reassurance or continued observation.

5. Category III means prepare for delivery – not more waiting. Category III strips require prompt evaluation and delivery if resuscitation measures do not improve the tracing. If a question describes absent variability with recurrent late decelerations and asks what the nurse should do, “notify provider and prepare for cesarean” is the priority answer.

6. Baseline variability is the most important single feature for category assignment. Moderate variability (6–25 bpm) is reassuring even when decelerations are present, though recurrent decelerations still need action. Absent variability with recurrent late or variable decelerations or bradycardia = Category III. Absent variability without recurrent decelerations or bradycardia = Category II, and it is still a higher-risk Category II feature. The variability finding drives category assignment more than any other single feature.

7. Recurrent vs occasional decelerations changes category assignment. “Recurrent” means the deceleration occurs with ≥50% of contractions in a 20-minute window. A single late deceleration with moderate variability is Category II. Recurrent late decelerations with moderate variability remain Category II but require more aggressive management than isolated events.

8. Document in NICHD language – and at the correct frequency. NCLEX may ask how often to assess the strip. AWHONN intervals for continuous EFM: every 30 minutes (active first stage, low-risk), every 15 minutes (active pushing, low-risk; or active first stage with oxytocin or risk factors), every 5 minutes (active pushing with oxytocin or risk factors). Hospital policy sets the charting interval, and a record that does not show assessment at the required frequency is a liability.

9. Left lateral is preferred over right lateral – but either relieves aortocaval compression. Questions sometimes offer both. Left lateral is first-line because it maximally displaces the uterus off the inferior vena cava and aorta. If left lateral does not improve the tracing, repositioning to right lateral or knee-chest position is appropriate.

10. Oxygen is no longer automatically the first intervention for every non-reassuring strip. ACOG Clinical Practice Guideline No. 10 (October 2025) recommends against routine oxygen for non-hypoxic patients with Category II or Category III tracings, and AWHONN agrees that oxygen should not be first-line. Repositioning, fluids, and stopping oxytocin take priority. Under ACOG’s guidance oxygen is given for maternal hypoxia; AWHONN still allows a short trial in selected high-risk tracings after other measures fail, so follow unit protocol. Know this distinction – older NCLEX questions may still reflect the previous “O₂ first” approach, but current best practice and newer exam items will reflect the updated guidance.

References

  1. Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstetrics & Gynecology. 2008;112(3):661–666. https://doi.org/10.1097/AOG.0b013e3181841395

  2. American College of Obstetricians and Gynecologists. Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstetrics & Gynecology. 2009;114(1):192–202. (Replaced by Clinical Practice Guideline No. 10, October 2025; listed for history.)

  3. American College of Obstetricians and Gynecologists. Clinical Practice Guideline No. 10: Intrapartum fetal heart rate monitoring: interpretation and management. Obstetrics & Gynecology. 2025;146(4):583–599. https://doi.org/10.1097/AOG.0000000000006049 (Replaces PB 106, PB 116, and the January 2022 oxygen practice advisory.)

  4. Lyndon A, Wisner K, eds. Fetal Heart Monitoring: Principles and Practices. 6th ed. Association of Women’s Health, Obstetric and Neonatal Nurses; Kendall Hunt; 2021.

  5. Alfirevic Z, Devane D, Gyte GM, Cuthbert A. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews. 2017;(2):CD006066. https://doi.org/10.1002/14651858.CD006066.pub3

  6. Cahill AG, Tuuli MG, Stout MJ, López JD, Macones GA. A prospective cohort study of fetal heart rate monitoring: deceleration area is predictive of fetal acidemia. American Journal of Obstetrics and Gynecology. 2018;218(5):523.e1–523.e12. https://doi.org/10.1016/j.ajog.2018.01.026

  7. Simpson KR, James DC. Efficacy of intrauterine resuscitation techniques in improving fetal oxygen status during labor. Obstetrics & Gynecology. 2005;105(6):1362–1368. https://doi.org/10.1097/01.AOG.0000164474.03350.7c

  8. Skupski DW, Rosenberg CR, Eglinton GS. Intrapartum fetal stimulation tests: a meta-analysis. Obstetrics & Gynecology. 2002;99(1):129–134. https://doi.org/10.1097/00006250-200201000-00024

  9. Association of Women’s Health, Obstetric and Neonatal Nurses. Fetal heart monitoring (position statement). Journal of Obstetric, Gynecologic & Neonatal Nursing. 2018;47(6):874–877. https://doi.org/10.1016/j.jogn.2018.09.007 (Revised 2024: JOGNN 2024;53(3):e5–e9, https://doi.org/10.1016/j.jogn.2024.03.001.)

  10. Parer JT, Ikeda T. A framework for standardized management of intrapartum fetal heart rate patterns. American Journal of Obstetrics and Gynecology. 2007;197(1):26.e1–26.e6. https://doi.org/10.1016/j.ajog.2007.03.037

  11. Clark SL, Nageotte MP, Garite TJ, et al. Intrapartum management of category II fetal heart rate tracings: towards standardization of care. American Journal of Obstetrics and Gynecology. 2013;209(2):89–97. https://doi.org/10.1016/j.ajog.2013.04.030

  12. Sholapurkar SL. The conundrum of vanishing early decelerations in British obstetrics, a step backwards? Detailed appraisal of British and American classifications of fetal heart rate decelerations – fallacies of emphasis on waveform and putative aetiology. Journal of Obstetrics and Gynaecology. 2012;32(6):505–511. https://doi.org/10.3109/01443615.2012.689029

  13. Nageotte MP. Fetal heart rate monitoring. Seminars in Fetal and Neonatal Medicine. 2015;20(3):144–148. https://doi.org/10.1016/j.siny.2015.02.002

  14. Devane D, Lalor JG, Daly S, McGuire W, Cuthbert A, Smith V. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews. 2017;(1):CD005122. https://doi.org/10.1002/14651858.CD005122.pub5

  15. Association of Women’s Health, Obstetric and Neonatal Nurses. AWHONN response to ACOG’s practice advisory on oxygen supplementation in the setting of category II or III fetal heart tracings. March 30, 2022. https://awhonn.org/wp-content/uploads/2022/04/AWHONNs-Response-to-ACOGs-Practice-Advisory-on-Oxygen-Supplementation-in-the-Setting-of-Catergory-II-or-III-Fetal-Heart-Tracings-1.pdf

  16. Raghuraman N, Temming LA, Doering MM, et al. Maternal oxygen supplementation compared with room air for intrauterine resuscitation: a systematic review and meta-analysis. JAMA Pediatrics. 2021;175(4):368–376. https://doi.org/10.1001/jamapediatrics.2020.5351

  17. Cahill AG, Roehl KA, Odibo AO, Macones GA. Association and prediction of neonatal acidemia. American Journal of Obstetrics and Gynecology. 2012;207(3):206.e1–206.e8. https://doi.org/10.1016/j.ajog.2012.06.046

  18. Jackson M, Holmgren CM, Esplin MS, Henry E, Varner MW. Frequency of fetal heart rate categories and short-term neonatal outcome. Obstetrics & Gynecology. 2011;118(4):803–808. https://doi.org/10.1097/AOG.0b013e31822f1b50

  19. Verdurmen KMJ, Warmerdam GJJ, Lempersz C, et al. The influence of betamethasone on fetal heart rate variability, obtained by non-invasive fetal electrocardiogram recordings. Early Human Development. 2018;119:8–14. https://doi.org/10.1016/j.earlhumdev.2018.02.011